Narbasa, Alicia .

HRN: 28-68-54  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/10/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/10/2026
03/10/2026
IV
300mg
Q6
Cellulitis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines